HFE hemochromatosis: an overview about therapeutic recommendations

Cancado, Rodolfo D; Alvarenga, Aline Morgan; Santos, Paulo Caleb J. L.
Hematol., Transfus. Cell Ther. (Impr.) ; 44(1): 95-99, Jan.-Mar. 2022. tab
Artículo en Inglés | LILACS | ID: biblio-1364881

Documentos relacionados

  1. Current German Guidelines on Diagnosis and Treatment of Secondary Hemochromatosis in Patients with Congenital Anemias.
  2. Concerns about new proposals for haemochromatosis screening - Authors' reply.
  3. Long-term phlebotomy successfully alleviated hepatic iron accumulation in a ferroportin disease patient with a mutation in SLC40A1: a case report.
  4. Haemochromatosis.
  5. Haemochromatosis in children: A national retrospective cohort promoted by the A.I.E.O.P. (Associazione Italiana Emato-Oncologia Pediatrica) study group.
  6. Concerns about new proposals for haemochromatosis screening.
  7. Concerns about new proposals for haemochromatosis screening.
  8. Hemochromatosis.
  9. What Is Hereditary Hemochromatosis?
  10. [Management of iron overload during pregnancy and childbirth in a patient with ferroportin disease].